Living With Prostate Cancer (LPC)

NCT03177759 | Completed

• 1 other identifier: PCSC-6
• Study Type: observational
• Target: 42
• Locations: 1 country
• Sites: 1

Brief Summary

This is a prospective evaluation to determine the effectiveness of the Prostate Cancer Supportive Care (PCSC) Program's group therapy program, Living with Prostate Cancer (LPC). LPC is an intervention which utilizes a small group format (5-7 participants with 2 leaders and a paraprofessional counselling student) to understand and learn how to manage emotional responses, depressive symptoms, and life stressors associated with prostate cancer. Data for this evaluation will be derived from a focus group (at 3 months) and self-report questionnaires that participants will complete immediately prior to the intervention, immediately following the intervention and at 3, 6, and 12-months post-intervention.

Conditions

Prostate Cancer

Outcome Measures

Primary Outcomes (1)

• Changes in depressive and anxiety symptoms

  Measured by the Beck Depression Inventory

  Baseline (pre-workshop), 3-Weeks (Post-workshop), 3-, 6- and 12 Months

Secondary Outcomes (5)

• Changes in overall well-being

  Baseline (pre-workshop), 3-Weeks (Post-workshop), 3-, 6- and 12 Months

• Changes in perceptions of masculinity

  Baseline (pre-workshop), 3-Weeks (Post-workshop), 3-, 6- and 12 Months

• Changes in perceptions of masculinity

  Baseline (pre-workshop), 3-Weeks (Post-workshop), 3-, 6- and 12 Months

• Group cohesion and dynamics

  3-Weeks (Post-workshop), 3-, 6- and 12 Months

• Patient-incurred costs for attending the session

  3-Weeks (Post-Workshop)

Eligibility Criteria

• Age: 18 Years+
• Sex: male
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

The LPC Workshops will only include men with a diagnosis of Prostate Cancer Stages 1 to 3.

You may qualify if:

• Men are eligible to participate in this evaluation if they:
• are older than 18 years old
• are willing to attend the "Living with Prostate Cancer" group therapy sessions from the PCSC Program\*
• are able to speak and read English such that they are able to understand the questionnaires
• have unimpaired cognitive function with an ability to understand the nature of the study
• are willing to complete questionnaires at 5 time points
• provide written informed consent
• to be able to participate in LPC groups, men must have recently received a diagnosis of PC Stages 1 to 3, or have recently been recommended to undergo a form of treatment following a period of active surveillance.

You may not qualify if:

• Men will be ineligible to participate in this evaluation if they:
• have difficulties reading or understanding English
• have psychotic symptoms, current severe alcohol or other drug dependence, unwillingness to refrain from substance use during the program, and/or significant cognitive impairment that would prevent them participating or providing full informed consent.

Sponsors & Collaborators

• Vancouver Prostate Centre: lead

Study Sites (1)

Vancouver Prostate Centre

Vancouver, British Columbia, V5Z 1M9, Canada

Location

MeSH Terms

Conditions

Prostatic Neoplasms

Condition Hierarchy (Ancestors)

Genital Neoplasms, Male; Urogenital Neoplasms; Neoplasms by Site; Neoplasms; Genital Diseases, Male; Genital Diseases; Urogenital Diseases; Prostatic Diseases; Male Urogenital Diseases

Study Officials

• David Kuhl, MD

  University of British Columbia

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 7, 2017
• First Posted: June 6, 2017
• Study Start: September 9, 2016
• Primary Completion: June 30, 2019
• Study Completion: August 31, 2019
• Last Updated: October 2, 2019

Record last verified: 2019-10

Data Sharing

• IPD Sharing: Will not share

Locations

CA (1)